335 related articles for article (PubMed ID: 27262709)
21. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
22. Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
Bhatia A; Sabin ND; Fisher MJ; Poussaint TY
Pediatr Radiol; 2023 Dec; 53(13):2723-2741. PubMed ID: 37864711
[TBL] [Abstract][Full Text] [Related]
23. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).
Wen PY; Cloughesy TF; Ellingson BM; Reardon DA; Fine HA; Abrey L; Ballman K; Bendszuz M; Buckner J; Chang SM; Prados MD; Pope WB; Gregory Sorensen A; van den Bent M; Yung WK
Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii36-47. PubMed ID: 25313237
[TBL] [Abstract][Full Text] [Related]
24. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
van den Bent MJ; Wefel JS; Schiff D; Taphoorn MJ; Jaeckle K; Junck L; Armstrong T; Choucair A; Waldman AD; Gorlia T; Chamberlain M; Baumert BG; Vogelbaum MA; Macdonald DR; Reardon DA; Wen PY; Chang SM; Jacobs AH
Lancet Oncol; 2011 Jun; 12(6):583-93. PubMed ID: 21474379
[TBL] [Abstract][Full Text] [Related]
25. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
26. Endpoints for clinical trials and revised assessment in neuro-oncology.
Butowski N; Chang SM
Curr Opin Neurol; 2012 Dec; 25(6):780-5. PubMed ID: 23007010
[TBL] [Abstract][Full Text] [Related]
27. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
[TBL] [Abstract][Full Text] [Related]
28. Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
Narita Y
Jpn J Clin Oncol; 2013 Jun; 43(6):587-95. PubMed ID: 23585688
[TBL] [Abstract][Full Text] [Related]
29. Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.
Reardon DA; Okada H
J Neurooncol; 2015 Jul; 123(3):339-46. PubMed ID: 25707876
[TBL] [Abstract][Full Text] [Related]
30. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
31. [Neuroradiological response criteria for malignant gliomas].
Bendszus M; Platten M
Nervenarzt; 2010 Aug; 81(8):950-5. PubMed ID: 20669003
[TBL] [Abstract][Full Text] [Related]
32. Current concepts in brain tumor imaging.
Norden AD; Pope WB; Chang SM
Am Soc Clin Oncol Educ Book; 2012; ():119-24. PubMed ID: 24451720
[TBL] [Abstract][Full Text] [Related]
33. Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
Ellingson BM; Brown MS; Boxerman JL; Gerstner ER; Kaufmann TJ; Cole PE; Bacha JA; Leung D; Barone A; Colman H; van den Bent MJ; Wen PY; Alfred Yung WK; Cloughesy TF; Goldin JG
Neuro Oncol; 2021 Feb; 23(2):189-198. PubMed ID: 33130879
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy and Response Assessment in Malignant Glioma: Neuro-oncology Perspective.
Bagley SJ; Desai AS; Nasrallah MP; O'Rourke DM
Top Magn Reson Imaging; 2020 Apr; 29(2):95-102. PubMed ID: 32271286
[TBL] [Abstract][Full Text] [Related]
35. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
[TBL] [Abstract][Full Text] [Related]
36. Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma.
Chang SM; Wen PY; Vogelbaum MA; Macdonald DR; van den Bent MJ
Neurooncol Pract; 2015 Dec; 2(4):205-209. PubMed ID: 31386074
[TBL] [Abstract][Full Text] [Related]
37. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
38. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.
Warren KE; Vezina G; Poussaint TY; Warmuth-Metz M; Chamberlain MC; Packer RJ; Brandes AA; Reiss M; Goldman S; Fisher MJ; Pollack IF; Prados MD; Wen PY; Chang SM; Dufour C; Zurakowski D; Kortmann RD; Kieran MW
Neuro Oncol; 2018 Jan; 20(1):13-23. PubMed ID: 28449033
[TBL] [Abstract][Full Text] [Related]
39. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.
Huang RY; Rahman R; Ballman KV; Felten SJ; Anderson SK; Ellingson BM; Nayak L; Lee EQ; Abrey LE; Galanis E; Reardon DA; Pope WB; Cloughesy TF; Wen PY
Clin Cancer Res; 2016 Feb; 22(3):575-81. PubMed ID: 26490307
[TBL] [Abstract][Full Text] [Related]
40. A Comparative Retrospective Study of Immunotherapy RANO
Chen X; Lim-Fat MJ; Qin L; Li A; Bryant A; Bay CP; Gao L; Miskin N; Liu Z; Iorgulescu JB; Xu X; Reardon DA; Young GS
Front Oncol; 2021; 11():679331. PubMed ID: 34249718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
